Literature DB >> 10443165

Quinolones: which generation for which microbe?

M K Lee1, M S Kanatani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443165      PMCID: PMC1305694     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  12 in total

Review 1.  Management of pulmonary disease in patients with cystic fibrosis.

Authors:  B W Ramsey
Journal:  N Engl J Med       Date:  1996-07-18       Impact factor: 91.245

2.  Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.

Authors:  R N Jones; E N Kehrberg; M E Erwin
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?

Authors:  M E Ernst; E J Ernst; M E Klepser
Journal:  Am J Health Syst Pharm       Date:  1997-11-15       Impact factor: 2.637

4.  Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.

Authors:  A Bauernfeind
Journal:  J Antimicrob Chemother       Date:  1997-11       Impact factor: 5.790

Review 5.  Avoiding fluoroquinolone resistance. Strategies for primary care practice.

Authors:  C W Stratton
Journal:  Postgrad Med       Date:  1997-03       Impact factor: 3.840

Review 6.  Classification and structure-activity relationships of fluoroquinolones.

Authors:  A Bryskier; J F Chantot
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 7.  Fluoroquinolone toxicities. An update.

Authors:  P S Lietman
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 8.  Clinical applications of quinolones.

Authors:  D C Hooper
Journal:  Biochim Biophys Acta       Date:  1998-10-01

Review 9.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 10.  Quinolones.

Authors:  B Suh; B Lorber
Journal:  Med Clin North Am       Date:  1995-07       Impact factor: 5.456

View more
  3 in total

Review 1.  Gatifloxacin: a review of its use in the management of bacterial infections.

Authors:  Caroline M Perry; Douglas Ormrod; Miriam Hurst; Susan V Onrust
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 3.  Chemical and Pharmacological Properties of Decoquinate: A Review of Its Pharmaceutical Potential and Future Perspectives.

Authors:  Tainá Santos Souza; Diogo Rodrigo Magalhães Moreira; Henrique Rodrigues Marcelino
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.